{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T01:31:10Z","timestamp":1792459870545,"version":"4.5.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T00:00:00Z","timestamp":1264982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T00:00:00Z","timestamp":1264982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,4,10]],"date-time":"2015-04-10T00:00:00Z","timestamp":1428624000000},"content-version":"vor","delay-in-days":1894,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2010,2]]},"DOI":"10.1016\/j.bbmt.2009.09.022","type":"journal-article","created":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T10:42:20Z","timestamp":1254393740000},"page":"231-238","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Outcome of 125 Children with Chronic Myelogenous Leukemia Who Received Transplants from Unrelated Donors: The Japan Marrow Donor Program"],"prefix":"10.1016","volume":"16","author":[{"given":"Hideki","family":"Muramatsu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiji","family":"Kojima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayami","family":"Yoshimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiko","family":"Atsuta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihisa","family":"Nagatoshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masami","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazutoshi","family":"Koike","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takakazu","family":"Kawase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaki","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidemitsu","family":"Kurosawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiko","family":"Tanizawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chikako","family":"Tono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuko","family":"Hamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriko","family":"Hotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiro","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuo","family":"Morishima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keisei","family":"Kawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Shimada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2009.09.022_bib1","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S0031-3955(16)36509-9","article-title":"Chronic leukemias of childhood","volume":"35","author":"Altman","year":"1988","journal-title":"Pediatr Clin North Am"},{"key":"10.1016\/j.bbmt.2009.09.022_bib2","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1055\/s-2008-1046479","article-title":"Prognosis of children with chronic myeloid leukemia: a retrospective analysis of 75 patients","volume":"208","author":"Creutzig","year":"1996","journal-title":"Klinische Padiatr"},{"key":"10.1016\/j.bbmt.2009.09.022_bib3","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1038\/sj.bmt.1704255","article-title":"Allogeneic bone marrow transplantation for chronic myeloid leukemia in childhood: a report from the Societe Francaise de Greffe de Moelle et de Therapie Cellulaire (SFGM-TC)","volume":"32","author":"Millot","year":"2003","journal-title":"Bone Marrow TransPlant"},{"key":"10.1016\/j.bbmt.2009.09.022_bib4","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1182\/blood-2002-12-3637","article-title":"Stem cell transplantation for chronic myeloid leukemia in children","volume":"102","author":"Cwynarski","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2009.09.022_bib5","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1200\/JCO.1993.11.5.834","article-title":"Unrelated-donor bone marrow transplantation for Philadelphia chromosome-positive chronic myelogenous leukemia in children","volume":"11","author":"Gamis","year":"1993","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2009.09.022_bib6","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1182\/blood-2006-02-005686","article-title":"Evolving concepts in the management of chronic myeloid leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet","volume":"108","author":"Baccarani","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2009.09.022_bib7","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1056\/NEJM200104053441401","article-title":"Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia","volume":"344","author":"Druker","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bbmt.2009.09.022_bib8","first-page":"513","volume":"91","author":"Gratwohl","year":"2006","journal-title":"Haematologica"},{"key":"10.1016\/j.bbmt.2009.09.022_bib9","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1182\/blood-2006-03-011239","article-title":"Imatinib mesylate discontinuation in patients with chronic myelogenous leukemia in complete molecular remission for more than 2 years","volume":"109","author":"Rousselot","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2009.09.022_bib10","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.leukres.2008.11.027","article-title":"Is it possible to discontinue imatinib mesylate therapy in chronic myeloid leukemia patients with undetectable BCR\/ABL? A case report and a review of the literature","volume":"33","author":"Guastafierro","year":"2009","journal-title":"Leuk Res"},{"key":"10.1016\/j.bbmt.2009.09.022_bib11","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S0140-6736(84)92179-2","article-title":"Allogeneic bone marrow transplantation for chronic myelogenous leukaemia","volume":"1","author":"Speck","year":"1984","journal-title":"Lancet"},{"key":"10.1016\/j.bbmt.2009.09.022_bib12","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/00007890-197410000-00001","article-title":"Clinical manifestations of\u00a0graft-versus-host disease in human recipients of marrow from HLA-matched sibling donors","volume":"18","author":"Glucksberg","year":"1974","journal-title":"TransPlantation"},{"key":"10.1016\/j.bbmt.2009.09.022_bib13","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1056\/NEJM197701132960201","article-title":"Marrow transplantation for treatment of aplastic anemia: an analysis of factors associated with graft rejection","volume":"296","author":"Storb","year":"1977","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bbmt.2009.09.022_bib14","doi-asserted-by":"crossref","first-page":"3930","DOI":"10.1182\/blood-2002-01-0339","article-title":"Transplant-related mortality and long-term graft function are significantly influenced by cell dose in patients undergoing allogeneic marrow transplantation","volume":"100","author":"Dominietto","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2009.09.022_bib15","doi-asserted-by":"crossref","first-page":"4226","DOI":"10.1182\/blood.V89.11.4226","article-title":"Transplantation of marrow cells from unrelated donors for treatment of high-risk acute leukemia: the effect of leukemic burden, donor HLA-matching, and marrow cell dose","volume":"89","author":"Sierra","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2009.09.022_bib16","first-page":"970","article-title":"Mortality of mice as affected by variation of the x-ray dose and number of nucleated rat bone marrow cells injected","volume":"17","author":"Gengozian","year":"1957","journal-title":"Cancer Res"},{"key":"10.1016\/j.bbmt.2009.09.022_bib17","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1182\/blood.V79.6.1612.1612","article-title":"Influence of cell dose and graft-versus-host reactivity on rejection rates after allogeneic bone marrow transplantation","volume":"79","author":"Uharek","year":"1992","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2009.09.022_bib18","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/sj.thj.6200108","article-title":"Stem cell transplantation for chronic myeloid leukaemia: the role of infused marrow cell dose","volume":"2","author":"Pocock","year":"2001","journal-title":"Hematol J"},{"key":"10.1016\/j.bbmt.2009.09.022_bib19","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/sj.leu.2404100","article-title":"Cytogenetic response to prior treatment with interferon-alpha is predictive for survival after allogeneic hematopoietic stem cell transplantation in chronic myeloid leukemia","volume":"20","author":"Maywald","year":"2006","journal-title":"Leukemia"},{"key":"10.1016\/j.bbmt.2009.09.022_bib20","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1080\/10428190601078464","article-title":"Allogeneic stem cell transplantation provides excellent results in advanced stage chronic myeloid leukemia with major cytogenetic response to pre-transplant imatinib therapy","volume":"48","author":"Weisser","year":"2007","journal-title":"Leuk LymPhoma"},{"key":"10.1016\/j.bbmt.2009.09.022_bib21","doi-asserted-by":"crossref","first-page":"3500","DOI":"10.1182\/blood-2008-02-141689","article-title":"Impact of prior imatinib mesylate on the outcome of hematopoietic cell transplantation for chronic myeloid leukemia","volume":"112","author":"Lee","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2009.09.022_bib22","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1182\/blood-2003-09-3032","article-title":"Imatinib mesylate (STI571) for treatment of children with Philadelphia chromosome\u2013positive leukemia: results from a Children's Oncology Group phase 1 study","volume":"104","author":"Champagne","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2009.09.022_bib23","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/sj.leu.2404051","article-title":"Imatinib mesylate is effective in children with chronic myelogenous leukemia in late chronic and advanced phase and in relapse after stem cell transplantation","volume":"20","author":"Millot","year":"2006","journal-title":"Leukemia"},{"key":"10.1016\/j.bbmt.2009.09.022_bib24","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1056\/NEJMoa062867","article-title":"Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia","volume":"355","author":"Druker","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bbmt.2009.09.022_bib25","doi-asserted-by":"crossref","first-page":"4022","DOI":"10.1182\/blood-2007-10-116475","article-title":"Imatinib pharmacokinetics and its correlation with response and safety in chronic-phase chronic myeloid leukemia: a subanalysis of the IRIS study","volume":"111","author":"Larson","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2009.09.022_bib26","doi-asserted-by":"crossref","first-page":"3496","DOI":"10.1182\/blood-2006-07-036012","article-title":"Trough imatinib plasma levels are associated with both cytogenetic and molecular responses to standard-dose imatinib in chronic myeloid leukemia","volume":"109","author":"Picard","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2009.09.022_bib27","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s12185-008-0251-8","article-title":"Growth deceleration in a girl treated with imatinib","volume":"89","author":"Kimoto","year":"2009","journal-title":"Int J Hematol"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879109004455?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879109004455?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:35:02Z","timestamp":1761057302000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083879109004455"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,2]]}},"alternative-id":["S1083879109004455"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2009.09.022","relation":{},"ISSN":["1083-8791"],"issn-type":[{"value":"1083-8791","type":"print"}],"subject":[],"published":{"date-parts":[[2010,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Outcome of 125 Children with Chronic Myelogenous Leukemia Who Received Transplants from Unrelated Donors: The Japan Marrow Donor Program","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2009.09.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}